News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diabetes Focused Alinea Pharmaceuticals Inks $45 Million Series A



10/19/2005 5:13:20 PM

10/11/2005. Alinea Pharmaceuticals Inc., a newly formed clinical stage start-up focused on the treatment of diabetes and metabolic disorders, has secured a $45 million Series A round, according to MPM Capital Venture Partner Todd Foley, a director at the company.



comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES